IMM 3.13% 31.0¢ immutep limited

a current prediction, page-79

  1. 135 Posts.
    lightbulb Created with Sketch. 84
    IMP761 has languished with no investment. 4 years of slow walking and giving updates. The Cyno data got me really excited for potential business development. It’s been a “pipeline product” in name only.
    https://pipelinereview.com/index.php/2017010363477/Antibodies/Prima-Announces-New-Product-Candidate-IMP761-A-LAG-3-Agonist-Antibody.html
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.